Dysglycemia in the critically ill patient: current evidence and future perspectives

Dysglycemia in critically ill patients (hyperglycemia, hypoglycemia, glycemic variability and time in range) is a biomarker of disease severity and is associated with higher mortality. However, this impact appears to be weakened in patients with previous diabetes mellitus, particularly in those with...

Descripción completa

Detalles Bibliográficos
Autores principales: Aramendi, Ignacio, Burghi, Gastón, Manzanares, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Medicina Intensiva Brasileira - AMIB 2017
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632980/
https://www.ncbi.nlm.nih.gov/pubmed/29044305
http://dx.doi.org/10.5935/0103-507X.20170054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632980/
https://www.ncbi.nlm.nih.gov/pubmed/29044305
http://dx.doi.org/10.5935/0103-507X.20170054

Ejemplares similares